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Abstract  
  
We evaluated the effects of Lycium barbarum polysaccharides LBP）on D-galactose aging model mouse, and explored 
its possible mechanism. Kunming mice were randomly divided into the control group, the model group, the high-dose LBP 
group, and the low-dose LBP group. Except the control group, D-galactose was used for modelling. The drug was 
administrated when modelling. Mouse behavioural, learning and memory changes were observed, and the contents of lipid 
peroxidation (LPO), lipofuscin (LF) and monoamine oxidase B (MAO-B) in mouse brain tissue and the weight of immune 
organs were measured after 6 weeks. Compared with the control group, mouse weight gain in the model group reduced 
significantly. Compared with model group, after mice drank LBP, the times of electric shock was less than aging mice (in 
which, the high-dose LBP group, P<0.05), and electric shock incubation period was longer (P<0.01). On Day 45 after 
modelling and drug administration, the contents of LPO, LF and MAO-B in mouse brain tissue in the model group increased 
significantly, while those in the drug administration groups decreased significantly. The thymus index in the aging model 
group decreased significantly; the thymus index and the spleen index in the high-dose LBP group and the low-dose LBP 
group rebounded significantly (P<0.01). We concluded that LBP has an anti-aging effect on D-galactose induced aging model 
mouse, and its mechanism may be related with the alleviation of glucose metabolism disorder and the resistance of the 
generation of lipid peroxide and other substances, which damage cell membrane lipid. 
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Introduction 
 
Barbary wolfberry fruit is the dried ripe fruit of Lycium barbarum L. （State Pharmacopeia Committee., 2010）, with 
immunity enhancing, liver protecting, blood sugar lowering, anti-tumour, blood pressure lowering, antioxidant, and 
anti-aging effects (Kim et al., 1997; Kim et al., 2000; Peng & Tian., 2001; Leung et al., 2001; Toyoda-Ono et al., 2004) and 
other functions, and is a traditional precious Chinese herbal medicine of long history. The chemical composition analysis on 
barbary wolfberry fruit shows that it mainly contains polysaccharides, amino acids, trace elements, vitamins, taurine, 
alkaloids, volatile oil and other chemical ingredients (Zhou & Li., 2009), in which, lycium barbarum polysaccharides (LBP), 
due to its significant pharmacological activity, becomes a research hotspot. This paper starts from the metabolism theory of 
aging, and uses D-galactose aging mouse model (Miao., 2002) to study the anti-aging effect of LBP and to preliminarily 
explore its anti-aging mechanism. 
 
 
Experimental materials 
Drug and reagents 
Drugs and reagents used for the study include the following: barbary wolfberry from Zhongning County, Ningxia 
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Province, China (which was identified by Professor Li Shixia of Central South University and deposited in the pharmacy 
centre); TBA (Shanghai Yongzheng Chemical Co., Ltd); TEP (Shanghai Weijing Biotechnology Co., Ltd); quinine sulphate 
(Shanghai Huyu Biology Co., Ltd.); benzylamine (Tianjin Jinhai Chemical Co., Ltd); perchloric acid (Tianjin Xinyuan 
Chemical Co., Ltd).  
 
Main instruments 
 
The main instruments for the study include the following: KQ-5200 ultrasonic extractor (Kunshan Ultrasonic 
Instrument Co., Ltd.); DT-200 jumping apparatus (Chengdu Taimeng Technology Co., Ltd); UV2100 ultraviolet and visible 
spectrophotometer (USA UNICO (Shanghai) Instrument Co., Ltd.); fluorescence spectrophotometer (Shanghai Jianglai 
Experimental Device Co., Ltd.); electric homogeniser (Zhenjiang Kemi Instrument & Meter Co., Ltd); GL-21M high-speed 
refrigerated centrifuge (Changsha Xiangyi Centrifuge Instrument Co., Ltd.) 
 
Experimental animals 
 
Kunming mice are of clean grade, female, body weight 26-32g 
 
Preparation of LBP 
 
Referring to the methods in literature (Ayiguli et al., 2007) and making appropriate improvements, the detailed method 
is described below. Weigh appropriate amount of dried barbary wolfberry, make twice backflow extractions with chloroform: 
methanol (2:1) in 50℃ water bath, 2 hours each time, discard the liquid, make ultrasonic extraction with the residue and 80% 
ethanol for three times, 20min each time, filter and discard the filtrate, make ultrasonic extractions with the residue and water 
for three times, 20min each time, filter, make low temperature concentration to the combined filtrate, add 95% ethanol, stand 
at low temperature for 24h, and get the crude polysaccharide extract after washing the extracted and filtered solids with 
absolute ethanol and acetone and vacuum drying. 
 
Animal grouping and drug administration 
 
48 mice were randomly divided into four groups, namely the control group, the model group, the high-dose LBP group 
and the low-dose LBP group (n=12). Drinking method was adopted for drug administration, with the dose of 1g / (kg•d) and 
3g / (kg•d). The model group and the control group used the equivalent amount of reference liquid. At the same time of drug 
administration, the mice in the model group and the drug administration groups were subcutaneously injected with 50% 
D-galactose in neck and back daily, 0.5ml per mouse, for continuous 6 weeks, and the mice in the control group were 
subcutaneously injected with equivalent amount of saline. Injection meets the sterile requirements. The indicators were 
determined at 6 weeks after modelling and drug administration. 
 
General behaviour observation 
 
During the experiment, we daily observed the general behavioural changes of mice, including feeding, activity, hair 
colour and others. We weighed the body weight of mice every 5 days, and observed the weight changes in all the groups. 
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Jumping test (Xu et al., 2003) 
 
6 weeks after modelling and drug administration, the mice were put into the response box to adapt for a few minutes,  
and then it was electrified. The mice would jump onto the platform to avoid shock; 5min training for each mouse was 
observed. After 24h, we put the trained mice onto the platform and started the test. We recorded the time of the first jump off 
the platform, denoted as electric shock incubation period, and recorded the total number of electric shocks within 5min. 
While testing, if the time of staying on the platform exceeded 5 min, the incubation period was deemed as 5 min. (Operating 
parameter: 28V; time: 5 min) 
 
Determination of LPO, LF and MAO-B in brain tissue 
 
After the behaviour experiment and at 45 days after modelling and drug administration, the mice were decapitated, and 
the whole brain (cerebellum removed) was taken out quickly and separated at the mid sagittal suture, one half for the 
determination of LPO and LF contents, and the other half for the determination of MAO-B activity. LPO content was 
determined by TBA reaction colorimetry; LF content was determined by the Sohal method. We weighed 100mg brain, added 
2ml chloroform - methanol (2:1) extract, homogenised and filtered. We washed the residue with the extract, combined the 
filtrates, added the extract to 5ml, and measured the fluorescence intensity on a fluorescence spectrometer. Emission 
wavelength was 435nm and excitation wavelength was 365nm. MAO-B activity was measured by the method of 
benzylamine. We took appropriate amount of fresh brain tissue, added 10 times of volume of pre-cooled 0.2mol/L phosphate 
buffer (pH 7.4), homogenised in a glass homogeniser in ice bath, and then made ultrasonic extraction for 20 seconds twice 
and at an interval of 30 seconds, centrifuge at 1000×g and 0℃ for 10 minutes. We discarded the sediment, centrifuged the 
supernatant at 17000×g and 4 for 30 minutes, and re-suspended the sediment with 0.2mol/L phosphate buffer. We took 
0.5ml above enzyme solution, added 0.3ml 8mmol/L benzylamine, and also added 2.5ml 0.2mol/L phosphate buffer (pH7.4). 
The blank tube was only added with 3.0ml 0.2mol/L phosphate buffer, and keep warm in a 37 water bath oscillator for 3 
hours, mixing once every 15 minutes. Then, we added 0.3ml 60% perchloric acid to terminate the reaction, added 4.0ml 
cyclohexane for mixing and extraction, centrifuged at 3000r/min for 10 minutes, and took the supernatant to measure the A 
value at 242nm. The difference between the groups was compared with the absolute hourly absorbance as the indicator 
(△A/h). 
 
Determination of immune organ mass index 
 
Mice were weighed before being killed, the thymus and spleen were weighed on an electronic tissue scale after cleaning, 
and the thymus index and spleen index were calculated. 
 
Statistical methods 
 
SPSS11.0 software was adopted to make the statistical analysis on the experimental results. T test was adopted for 
intergroup mean comparison. One-way analysis of variance was adopted for multi-group mean comparison. 
 
Results 
Results of general behaviour observation 
 
Before modelling, the mice in all the groups had normal activity, sensitive response, bright hair colour and normal diet. 
Compared with the control group 1 week after modelling, the mice in the model group had slow response, somnolence, 
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decreased diet, reduced body weight, less activity, and dried and dull hair. The abnormal changes in the high-dose LBP group 
and the low-dose LBP group were remitted at various degrees. 
 
Body weight change after 6 weeks is shown in Table 3-1. 
Table 1: Effect of LBP on body weight of D-galactose-caused aging mice (n=12) (
—
X ±S) 
Group Body weight change after 6 weeks (g) 
The control group 6.4±1.07 
The model group 1.3±0.75◇◇ 
The low-dose LBP group 3.1±1.01﹡﹡ 
The high-dose LBP group 4.6±1.08﹡﹡ 
◇◇Compared with the control group, P<0.01; ﹡﹡Compared with the model group, P<0.01 
 
Results of jumping test 
 
The results of the jumping test are shown in Table 3-2. The results show that after the mice drank LBP, the number of 
electric shocks are less than that for aging mice (the high-dose LBP group, P<0.05), and the electric shock incubation period 
prolongs (P<0.01), indicating that mouse memory and learning ability are enhanced and LBP has the effects of improving 
animal learning and memory behaviour. 
Table 2: Results of jumping test (
—
X ±S) 
Group Number of animals (n) Jumping incubation 
period (s) 
Number of errors in 5min 
The control group 12 82.92±39.19﹡﹡ 5.83±1.85﹡﹡ 
The model group 12 39.17±22.64 8.75±2.90 
The low-dose LBP group 12 89.83±43.13﹡﹡ 6.92±2.94 
The high-dose LBP group 12 95.75±49.26﹡﹡ 6.58±2.71﹡ 
﹡﹡Compared with the model group, P<0.01; ﹡Compared with the model group, P<0.05 
 
Results of determination of LPO, LF and MAO-B contents in brain tissue 
 
The results of determination of LPO, LF and MAO-B contents in brain tissue are shown in Table 3-3. 45 days after 
modelling and drug administration, LPO, LF and MAO-B contents in brain tissue in the model group increased significantly, 
and compared with the model group, those in the drug administration groups decreased significantly. 
 
Table 3: Results of determination of LPO, LF and MAO-B contents in brain tissue in aging mice (
—
X ±S, n=12) 
Group LPO (nmol/mg tissue) LF fluorescence value MAO-B (△A/h) 
The control group 10.58±1.93﹡ 17.83±1.75﹡﹡ 0.188±0.036﹡﹡ 
The model group 12.67±2.77 19.58±1.44 0.231±0.024 
The low-dose LBP group 10.17±2.17﹡ 13.17±1.99﹡﹡ 0.194±0.022﹡﹡ 
The high-dose LBP group 9.83±1.99﹡﹡ 15.83±1.95﹡﹡ 0.177±0.017﹡﹡ 
﹡﹡Compared with the model group, P<0.01; ﹡Compared with the model group, P<0.05 
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Results of determination of immune organ mass index 
 
The results of determination of immune organ mass index are shown in Table 3-4. The thymus index in the model group 
decreased significantly; the thymus index and the spleen index in the high-dose LBP group and the low-dose LBP group 
rebounded significantly. 
Table 4: Results of determination of thymus index and spleen index in aging mice (
—
X ±S, n=12) 
Group Thymus index (mg/10g body 
weight) 
Spleen index (mg/10g body weight) 
The control group 22.83±1.59﹡﹡ 41.92±2.81 
The model group 19.58±1.62 40.33±2.99 
The low-dose LBP group 26.33±1.37﹡﹡ 46.42±3.53﹡﹡ 
The high-dose LBP group 24.42±1.78﹡﹡ 46.17±3.13﹡﹡ 
﹡﹡Compared with the model group, P<0.01 
 
Discussion 
 
The metabolism theory of aging explains that aging is the result of body metabolism disorders. At continuous injection 
of D-galactose in animals within certain time, the galactose concentration increases. It will inevitably cause glucose 
metabolism disorder, thereby causing abnormal metabolism of heart, liver, kidney, brain and other important organs. 
Meanwhile, some products damaging cell membrane lipid are generated during the process that galactose is reduced into 
galactitol, such as the increases of lipid peroxidation and lipofuscin, finally leading to body aging (Cui et al., 2006), The 
results of this study show that the mice in the aging model group show significant aging symptoms in signs and the jumping 
test. The memory and learning abilities were in disorder, the incubation period reduced significantly, the number of errors 
increased significantly, and the number of electric shocks increased. After the mice drank LBP, compared with the aging 
model group, the memory and learning ability increased (P<0.05 or P<0.01). LPO, LF and MAO-B contents in brain tissue 
relatively reduced. The above experimental results show that LBP has certain therapeutic effects on mouse brain function 
decline caused by D-galactose, providing the basis for the development of traditional Chinese medicine for the treatment of 
brain degenerative diseases. 
Thymus, as the central immune organ, mainly mediates cellular immune response. The thymus index decreases, 
indicating that thymocyte proliferation and differentiation capacity and cellular immune function decrease. Spleen, as the 
second level of immune organ, is mainly involved in humoral immunity; it is the organ generated by antibodies, and it can 
remove senescent cells, microorganisms and other substances. Therefore, thymus and spleen are closely related with body 
aging. This study shows that LBP can delay the atrophy of thymus and spleen of aging mice, thereby preventing the decline 
of cellular immune and humoral immune functions, and has the effect of slowing aging to a certain extent. This experiment is 
simple and reliable in method, short in experiment period, small in individual difference and stable in repeatability (Zhao & 
Yang., 1999; Xu et al., 2003). 
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